DYN logo

Dyne Therapeutics (DYN) Free cash flow

annual FCF:

-$294.75M-$105.86M(-56.04%)
December 31, 2024

Summary

  • As of today (May 29, 2025), DYN annual free cash flow is -$294.75 million, with the most recent change of -$105.86 million (-56.04%) on December 31, 2024.
  • During the last 3 years, DYN annual FCF has fallen by -$171.56 million (-139.28%).
  • DYN annual FCF is now -6757.72% below its all-time high of -$4.30 million, reached on December 31, 2018.

Performance

DYN Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

quarterly FCF:

-$106.87M-$21.46M(-25.13%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN quarterly free cash flow is -$106.87 million, with the most recent change of -$21.46 million (-25.13%) on March 31, 2025.
  • Over the past year, DYN quarterly FCF has dropped by -$28.15 million (-35.75%).
  • DYN quarterly FCF is now -1350.32% below its all-time high of -$7.37 million, reached on June 30, 2020.

Performance

DYN quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

TTM FCF:

-$322.89M-$28.15M(-9.55%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN TTM free cash flow is -$322.89 million, with the most recent change of -$28.15 million (-9.55%) on March 31, 2025.
  • Over the past year, DYN TTM FCF has dropped by -$102.41 million (-46.45%).
  • DYN TTM FCF is now -4205.79% below its all-time high of -$7.50 million, reached on March 31, 2020.

Performance

DYN TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

DYN Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-56.0%-35.8%-46.5%
3 y3 years-139.3%-105.0%-105.8%
5 y5 years-2086.4%-1325.2%-4205.8%

DYN Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-139.3%at low-259.7%at low-128.7%at low
5 y5-year-2086.4%at low-1350.3%at low-4205.8%at low
alltimeall time-6757.7%at low-1350.3%at low-4205.8%at low

DYN Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$106.87M(+25.1%)
-$322.89M(+9.5%)
Dec 2024
-$294.75M(+56.0%)
-$85.41M(+14.1%)
-$294.75M(+20.6%)
Sep 2024
-
-$74.88M(+34.4%)
-$244.42M(+10.9%)
Jun 2024
-
-$55.73M(-29.2%)
-$220.31M(-0.1%)
Mar 2024
-
-$78.73M(+124.4%)
-$220.48M(+16.7%)
Dec 2023
-$188.89M(+20.5%)
-$35.09M(-30.9%)
-$188.89M(+2.9%)
Sep 2023
-
-$50.77M(-9.2%)
-$183.51M(+4.0%)
Jun 2023
-
-$55.89M(+18.6%)
-$176.43M(+16.3%)
Mar 2023
-
-$47.14M(+58.7%)
-$151.71M(-3.2%)
Dec 2022
-$156.71M
-$29.71M(-32.0%)
-$156.71M(-0.2%)
Sep 2022
-
-$43.69M(+40.2%)
-$157.06M(+11.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$31.17M(-40.2%)
-$141.20M(-10.0%)
Mar 2022
-
-$52.14M(+73.5%)
-$156.92M(+27.4%)
Dec 2021
-$123.18M(+158.4%)
-$30.06M(+8.0%)
-$123.18M(+8.2%)
Sep 2021
-
-$27.83M(-40.6%)
-$113.88M(+16.1%)
Jun 2021
-
-$46.89M(+154.8%)
-$98.09M(+67.5%)
Mar 2021
-
-$18.40M(-11.4%)
-$58.57M(+22.9%)
Dec 2020
-$47.67M(+253.6%)
-$20.76M(+72.4%)
-$47.67M(+77.1%)
Sep 2020
-
-$12.04M(+63.4%)
-$26.91M(+81.0%)
Jun 2020
-
-$7.37M(-1.7%)
-$14.87M(+98.3%)
Mar 2020
-
-$7.50M
-$7.50M
Dec 2019
-$13.48M(+213.7%)
-
-
Dec 2018
-$4.30M
-
-

FAQ

  • What is Dyne Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Dyne Therapeutics?
  • What is Dyne Therapeutics annual FCF year-on-year change?
  • What is Dyne Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Dyne Therapeutics?
  • What is Dyne Therapeutics quarterly FCF year-on-year change?
  • What is Dyne Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Dyne Therapeutics?
  • What is Dyne Therapeutics TTM FCF year-on-year change?

What is Dyne Therapeutics annual free cash flow?

The current annual FCF of DYN is -$294.75M

What is the all time high annual FCF for Dyne Therapeutics?

Dyne Therapeutics all-time high annual free cash flow is -$4.30M

What is Dyne Therapeutics annual FCF year-on-year change?

Over the past year, DYN annual free cash flow has changed by -$105.86M (-56.04%)

What is Dyne Therapeutics quarterly free cash flow?

The current quarterly FCF of DYN is -$106.87M

What is the all time high quarterly FCF for Dyne Therapeutics?

Dyne Therapeutics all-time high quarterly free cash flow is -$7.37M

What is Dyne Therapeutics quarterly FCF year-on-year change?

Over the past year, DYN quarterly free cash flow has changed by -$28.15M (-35.75%)

What is Dyne Therapeutics TTM free cash flow?

The current TTM FCF of DYN is -$322.89M

What is the all time high TTM FCF for Dyne Therapeutics?

Dyne Therapeutics all-time high TTM free cash flow is -$7.50M

What is Dyne Therapeutics TTM FCF year-on-year change?

Over the past year, DYN TTM free cash flow has changed by -$102.41M (-46.45%)
On this page